Coloplast A/S (OTCMKTS:CLPBY) Issues Earnings Results, Beats Estimates By $0.01 EPS

Coloplast A/S (OTCMKTS:CLPBY) announced its quarterly earnings results on Friday. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01, reports. Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. The company had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.12 billion.

Coloplast A/S Stock Down 7.2%

Shares of CLPBY stock traded down $0.60 during trading on Friday, reaching $7.78. The company’s stock had a trading volume of 318,252 shares, compared to its average volume of 391,913. Coloplast A/S has a 1-year low of $7.75 and a 1-year high of $11.44. The stock’s 50-day moving average price is $8.67 and its 200 day moving average price is $9.09. The company has a market capitalization of $17.53 billion, a price-to-earnings ratio of 32.40, a P/E/G ratio of 0.83 and a beta of 0.26. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.61 and a quick ratio of 1.00.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.